Centiva Capital »

An2 Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $257k 75k 3.42

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors (TSLA)
Apple (AAPL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr China Lg-cap Etf (FXI)
Ishares Silver Tr Ishares Call Option (SLV)
Spdr Series Trust State Street Spd (KRE)

View all positions for Centiva Capital

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
Almitas Capital
Vanguard Group
Vanguard Capital Management
Woodline Partners
Ameriprise Financial
Stonepine Capital Management
Ally Bridge Group
Bank of Nova Scotia
Bank of America Corporation
Renaissance Technologies
BlackRock
Jane Street

View all funds holding An2 Therapeutics